Evaluation of the clinical applicability of artificial intelligence in determining systemic therapy indications and treatment selection in psoriasis

Journal of Dermatological Treatment · Available online 20 Jun 2026 · In press · DOI 10.1080/09546634.2026.2691339

Free full text

Authors (3)

Yoshihito Mima, Masako Yamamoto, Ken Iozumi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Mima, Y., Yamamoto, M., Iozumi, K. (2026). Evaluation of the clinical applicability of artificial intelligence in determining systemic therapy indications and treatment selection in psoriasis. Journal of Dermatological Treatment. https://doi.org/10.1080/09546634.2026.2691339

Related articles

• Raising the bar of efficacy in Atopic Dermatitis: deep response in week 16 responders treated with lebrikizumab over 2 years · Journal of Dermatological Treatment · 2026 · Same journal
• Comparative efficacy and safety of platelet-rich plasma (PRP), injectable platelet-rich fibrin (i-PRF) and concentrated growth factors (CGF) for female pattern hair loss (FPHL): a prospective multicenter randomized clinical trial · Journal of Dermatological Treatment · 2026 · Same journal
• Early response to ivarmacitinib and its impact on long-term efficacy in patients with moderate-to-severe atopic dermatitis: a post hoc analysis of a phase-III trial · Journal of Dermatological Treatment · 2026 · Same journal
• Healthcare resource use of patients with mild-moderate psoriasis on systemic treatments: a UK single-center longitudinal retrospective cohort study · Journal of Dermatological Treatment · 2026 · Same journal
• Effect of methotrexate on endothelial function in psoriasis patients · Journal of Dermatological Treatment · 2026 · Same journal
• Long-term benefits of upadacitinib for Atopic Dermatitis: deep responses in patient-reported outcomes over 140 weeks from the Measure Up 1 and Measure Up 2 clinical trials · Journal of Dermatological Treatment · 2026 · Same journal
• Distinct ocular safety profiles of dupilumab and upadacitinib in atopic dermatitis: a real-world study with ophthalmological and microbiological assessment · Journal of Dermatological Treatment · 2026 · Same journal
• Recalcitrant tinea infections due to Trichophyton indotineae in the United States (2025–2026): a retrospective case series identified by real-time PCR · Journal of Dermatological Treatment · 2026 · Same journal
• Safety and effectiveness of omalizumab for chronic spontaneous urticaria inadequately controlled with H1 antihistamines in Chinese adolescents: a real-world, prospective, multicenter study · Journal of Dermatological Treatment · 2026 · Same journal
• Deprescribing in dermatology · Journal of Dermatological Treatment · 2026 · Same journal